JUUL Lawsuit: How the Vaping Litigation Ended (2026)

What the JUUL Lawsuit Was About and Why People Sued

The JUUL lawsuit claimed the company sold an addictive product to kids and hid how strong it was. JUUL is an electronic cigarette paired with a prefilled nicotine cartridge called a JUULpod.

The federal panel that grouped the cases summed up the core claims. Plaintiffs said JUUL Labs built its marketing to appeal to minors and failed to tell buyers that its pods were more potent and addictive than cigarettes. They also argued the product was defective because it drew in young users, and that the company pushed nicotine addiction. Both group cases for buyers and individual injury cases were part of the mix.

Tobacco giant Altria Group, Inc. was named as a defendant too. Buyers said the two companies worked together to grow sales by hooking people who had never smoked, including teens.

Federal regulators raised similar concerns. In a September 2019 FDA warning letter, the agency said a JUUL representative told students the product was "99% safer" than cigarettes and "totally safe." The FDA said the company had no approval to make those kinds of safety claims.

How the Federal Case Unfolded

The case started small. When the panel created the MDL, it had 10 cases from five federal districts and notice of more than 40 related ones. It chose the Northern District of California because JUUL Labs was based there and Judge Orrick already handled several of the early cases.

An MDL, or multidistrict litigation, groups similar federal lawsuits under one judge for pretrial work. Each person keeps their own case, but evidence gathering happens once instead of thousands of times.

The fight was long. In May 2020, the court appointed Thomas J. Perrelli as settlement master to lead talks between the sides. Plaintiffs took more than 100 depositions, and the companies turned over millions of pages of records.

In June 2022, Judge Orrick certified four classes of JUUL buyers to move forward as a class action lawsuit, including groups for people who bought while under 18. The companies appealed, and the Ninth Circuit agreed to hear it. When Altria settled, it was in the middle of a trial with a separate plaintiff.

JUUL Lawsuit Settlements

Settlements with JUUL Labs and Altria resolved almost every claim in the federal case. The deals covered personal injury plaintiffs, school districts, local governments, tribes, and millions of product buyers.

JUUL Labs Deals

JUUL Labs settled first. Its December 2022 announcement covered injury, buyer class, government, and tribal claims. The company did not reveal the total amount and said it had lined up new investment to pay for the deal. The buyer class share was $255 million, which the court called adequate given the risks of trial.

Altria Deals

Altria's $235 million deal in May 2023 covered about 4,500 personal injury cases, about 1,500 government cases (roughly 1,400 of them from school districts), about 50 buyer class cases, and 750 cases in a related California state court proceeding. It did not cover three state attorney general cases, 35 tribal cases, 17 antitrust cases, or three Canadian cases.

Separately, Altria paid $45,531,250 into the buyer class fund. Together with JUUL Labs' payment, the class recovered more than $300 million.

How Class Members Were Paid

Claims poured in. The settlement administrator received 6,349,982 claims under the JUUL Labs deal and about 8.1 million more under the Altria deal. Many were duplicates or showed signs of fraud, and early estimates put valid claims at around 2 million.

The payment plan followed a few simple rules. People without receipts could claim up to $300 in purchases, while those with proof of purchase had no cap. People who first bought JUUL while underage earned larger payments, because the court treated each youth purchase as fully illegal. Payment options included check, direct deposit, PayPal, and prepaid card.

In March 2026, the court approved a second round of checks for people who took part in the first payout. No new claims were accepted.

State Attorney General Settlements

States ran their own investigations outside the MDL. In September 2022, 34 states and territories reached a $438.5 million agreement with JUUL Labs. The company could pay over six to 10 years, with the total rising to $476.6 million if it took the full 10 years.

The deal also limited how JUUL could sell. It banned marketing to anyone under 35, cartoons, paid influencers, free samples, and billboard ads, and it required age checks on all sales.

FDA Decisions Alongside the Lawsuits

While the lawsuits moved forward, JUUL's right to sell its products was also in question. On June 23, 2022, the FDA ordered JUUL products off the market, saying it lacked data to judge their health risks. The agency paused that order on July 5, 2022, and withdrew it in June 2024 to review the applications again.

In July 2025, the FDA authorized several JUUL products for adult use, including tobacco and menthol pods. On August 28, 2026, it also cleared the JUUL2 device and two of its pods. These decisions govern what JUUL can sell today. They do not reopen the claims already settled.

Where the JUUL Case Stands in 2026

The federal case is winding down but not formally closed. As of September 1, 2026, only 11 of 7,071 cases remain on the docket. Recent court activity has focused on paying out the remaining settlement money.

For most people, the settlement windows have passed. Anyone who thinks they still have a separate injury claim should know that filing deadlines, called statutes of limitations, differ by state and by type of injury. Speaking with a lawyer in your state may be a good way to learn whether any time remains.